Johns Hopkins ABX Guide
Amikacin
Amikacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Amikacin sulfate indicated in the short-term treatment of serious infections due to susceptible organisms
- [With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections including treatment of Pseudomonas aeruginosa.]
- Bacterial septicemia (including neonatal sepsis)
- Respiratory tract infections
- Bone and joint infections
- Central nervous system infections
- Skin and soft tissue infections (including burns, postoperative infections)
- Intra-abdominal infections
- Complicated and recurrent urinary tract infections.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
- Tuberculosis
- Non-tubercular mycobacterial (NTM) infections, MAI
- Nocardia
- Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Amikacin sulfate indicated in the short-term treatment of serious infections due to susceptible organisms
- [With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections including treatment of Pseudomonas aeruginosa.]
- Bacterial septicemia (including neonatal sepsis)
- Respiratory tract infections
- Bone and joint infections
- Central nervous system infections
- Skin and soft tissue infections (including burns, postoperative infections)
- Intra-abdominal infections
- Complicated and recurrent urinary tract infections.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
- Tuberculosis
- Non-tubercular mycobacterial (NTM) infections, MAI
- Nocardia
- Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 8, 2020
Citation
Dzintars, Kathryn. "Amikacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540015/7/Amikacin.
Dzintars K. Amikacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540015/7/Amikacin. Accessed March 21, 2023.
Dzintars, K. (2020). Amikacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540015/7/Amikacin
Dzintars K. Amikacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2023 March 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540015/7/Amikacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amikacin
ID - 540015
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2020/03/08/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540015/7/Amikacin
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
